Cencora, Inc. vs Eli Lilly & Co.
COR vs LLY — side-by-side comparison from reported financials. COR leads 5, LLY leads 7 of 12 comparable metrics.
Cencora, Inc.
COR · Healthcare
$323.85+0.78%Solid
Eli Lilly & Co.
LLY · Healthcare
$1 177.20+0.65%Solid
| Metric | COR | LLY |
|---|---|---|
| Price | $323.85 | $1 177.20 |
| Market cap | $61.8B | $1.05T |
| Revenue (TTM) | $333B | $79.7B |
| Revenue growth | +10.4% | +31.7% |
| Net margin | 0.8% | 33.5% |
| Free cash flow | $4.06B | $18.2B |
| Net cash (debt) | ($3.30B) | ($35.2B) |
| 1-year price return | +3.1% | +37.6% |
| P/E | 23.5 | 41.6 |
| P/E vs own history (cheap-side %) | 83% | 88% |
| Dividend yield | 0.76% | 0.52% |
| Return on equity | 106% | 93% |
| Altman Z-score | 3.66 | 7.10 |
| CV checks passed | 10 of 11 | 11 of 11 |
| Employees | 51,000 | 50,000 |
Full résumé-style profiles: COR CV · LLY CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.